Einträge von Habs, Michael auf dem Publikationsserver
 | Eine Stufe nach oben |
Anzahl der Einträge: 3.
2020
Habs, Michael und Koller, Michael 
(2020)
Material Risks of Homeopathic Medicinal Products: Regulatory Frameworks, Results of Preclinical Toxicology, and Clinical Meta-Analyses and Their Implications.
Complementary Medicine Research 21 (1), S. 64-84.
2018
Habs, Michael, Binder, Karin , Krauss, Stefan , Müller, Karolina, Ernst, Brigitte, Valentini, Luzia und Koller, Michael
(2018)
A Balanced Risk-Benefit Analysis to Determine Human Risks Associated with Pyrrolizidine Alkaloids (PA)—The Case of Herbal Medicinal Products Containing St. John’s Wort Extracts (SJW).
Nutrients 10 (7), S. 804.
Zugang zum Volltext eingeschränkt.
, Krauss, Stefan , Müller, Karolina, Ernst, Brigitte, Valentini, Luzia und Koller, Michael
(2018)
A Balanced Risk-Benefit Analysis to Determine Human Risks Associated with Pyrrolizidine Alkaloids (PA)—The Case of Herbal Medicinal Products Containing St. John’s Wort Extracts (SJW).
Nutrients 10 (7), S. 804.
Zugang zum Volltext eingeschränkt.
2017
Habs, Michael, Binder, Karin , Krauss, Stefan , Müller, Karolina, Ernst, Brigitte, Valentini, Luzia und Koller, Michael
(2017)
A Balanced Risk–Benefit Analysis to Determine Human Risks Associated with Pyrrolizidine Alkaloids (PA)—The Case of Tea and Herbal Infusions.
Nutrients 9 (7), S. 717.